Sepsis is a common condition managed in the emergency department. Current diagnosis relies on physiologic criteria and suspicion of a source of infection using history, physical examination, laboratory studies, and imaging studies. The infection triggers a host response with the aim to destroy the pathogen, and this response can be measured. A reliable biomarker for sepsis should assist with earlier diagnosis, improve risk stratification, or improve clinical decision making. Current biomarkers for sepsis include lactate, troponin, and procalcitonin. This article discusses the use of lactate, procalcitonin, troponin, and novel biomarkers for use in sepsis.
from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2gQqN2T
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Prolonged QT interval (long QTc) predisposes to torsades de pointes, which can present with seizures, syncope, and sudden death. (...
-
Researchers found that cardiac arrest survival rates remain low in the U.K. due to the lack of knowledge and skills to perform CPR from EM...
-
Abstract Introduction Population-based knowledge on the occurrence of specific injuries is essential for the allocation of health care s...
-
No abstract available from Emergency Medicine via xlomafota13 on Inoreader https://ift.tt/2SVDgBd
-
AbstractIntroductionThreatened, perforated, and infarcted bowel is managed with conventional resection and anastomosis (hand sewn (HS) or st...
-
Objectives Self-rated health (SRH) is an important patient-reported outcome, but little is known about SRH after a visit to the emergency de...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου